DaVita Clinical Research Expands in Denver
DaVita Clinical Research, a provider of clinical research services focused on kidney research and a variety of other specialty therapeutic populations, announced an agreement to enter the St. Anthony Hospital campus in Lakewood, Colo. The 80-bed facility will be operational in early 2012 and is expected to create more than 50 specialized research jobs.
“We are excited about our partnership with a hospital that has such a strong reputation with healthcare professionals and patients throughout Colorado,” said Kent Thiry, DaVita Chairman and CEO.
The hospital-based site increases DCR’s physical capacity from 42 to 122 beds in North America. The facility will support high-risk studies and an expanded ability to support normal, healthy volunteer Phase I clinical studies. The custom-designed facility will provide DCR with the capacity needed to grow its clinical research business in existing specialty populations, including renal patients.
The 35,000-square-foot unit will be physically connected to St. Anthony Hospitalin Medical Office Plaza South. St. Anthony Hospital, a full-service hospital and Level I Trauma Center, opened its doors in Lakewood in June 2011 after 119 years in its central Denver location.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.
